Rapid Micro Biosystems, Inc. (RPID)
NASDAQ: RPID · Real-Time Price · USD
3.980
-0.050 (-1.24%)
At close: Dec 5, 2025, 4:00 PM EST
4.050
+0.070 (1.76%)
After-hours: Dec 5, 2025, 7:29 PM EST
Rapid Micro Biosystems Market Cap
Rapid Micro Biosystems has a market cap or net worth of $176.4 million as of December 5, 2025. Its market cap has increased by 272.65% in one year.
Market Cap
176.40M
Enterprise Value
139.74M
1-Year Change
272.65%
Ranking
Category
Stock Price
$3.98
Market Cap Chart
Since the IPO on July 15, 2021, Rapid Micro Biosystems's market cap has decreased from $799.07M to $176.40M, a decrease of -77.92%. That is a compound annual growth rate of -29.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 176.40M | 355.46% |
| Dec 31, 2024 | 38.73M | 23.41% |
| Dec 29, 2023 | 31.38M | -33.87% |
| Dec 30, 2022 | 47.45M | -89.21% |
| Dec 31, 2021 | 439.99M | -44.94% |
| Jul 15, 2021 | 799.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 908.36B |
| Johnson & Johnson | 487.83B |
| AbbVie | 404.22B |
| UnitedHealth Group | 302.09B |
| AstraZeneca | 279.81B |
| Novartis AG | 255.73B |
| Merck & Co. | 250.41B |
| Abbott Laboratories | 218.05B |